United States · 
Who invested in SalioGen Therapeutics?
SalioGen Therapeutics's investors include Fidelity and IQ Capital.
United States · Series B startup
Who invested in SalioGen Therapeutics
Funding summaryUpdated 26 Oct 2026
$115Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $115MJan 2022
- Investors
- 2
The rounds
- Jan 2022
Founders and team
From the SEC filings it signed: 3 on the team.
- Joseph HigginsExecutive Officer, Directori
- Raymond TabibiazarExecutive Officer, Directori
- Sukumar NagendranWhile no offering proceeds are set aside for payments to the named officers or directors, it is possible that some procei
On the board, as filediCraig GordonSean Stalfort
Everyone who backed them
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about SalioGen Therapeutics
How much has SalioGen Therapeutics raised?
SalioGen Therapeutics has raised $115M across 1 round since 2022.
When did SalioGen Therapeutics last raise?
SalioGen Therapeutics's most recent round was a Series B of $115M in Jan 2022.
What was SalioGen Therapeutics's biggest round?
Its most recent round, $115M in Jan 2022, is also its largest on record.
Who backed SalioGen Therapeutics first?
SalioGen Therapeutics's first round on record, in Jan 2022, was backed by Fidelity and IQ Capital.
What stage is SalioGen Therapeutics at?
SalioGen Therapeutics's latest named round is a Series B, in Jan 2022.
Where is SalioGen Therapeutics based?
SalioGen Therapeutics is based in the United States.
Companies like SalioGen Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.